Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanket Patil

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Oncotarget|December 1, 2022
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Oncotarget|November 27, 2020
A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Global Medical Genetics|July 24, 2024
Analyzing Cell-free Genomic DNA in Spent Culture Media: Noninvasive Insight into the BlastocystsSiddhartha Shankar Layek, Shrushti Kanani, Shilpa Doultani, et al.
Oncotarget|November 23, 2020
Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapyRajnish Nagarkar, Darshana Patil, Sewanti Limaye, et al.
Oncotarget|November 7, 2022
Addendum: Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapyRajnish Nagarkar, Darshana Patil, Sewanti Limaye, et al.
Clinical Case Reports|November 12, 2021
Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinomaSewanti Limaye, Darshana Patil, Dadasaheb Akolkar, et al.
Frontiers in Molecular Medicine|August 1, 2024
Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory CancersTimothy Crook, Darshana Patil, Rajnish Nagarkar, et al.
Cost Effectiveness and Resource Allocation : C/E|January 12, 2026
Out-of-pocket expenditure in patients with isolated traumatic brain injury: a two center cohort study, a preliminary reportHarshit Arora, Sanket Patil, Pranav Bhatia, et al.
International Journal of Cancer|December 1, 2019
Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancerDadasaheb Akolkar, Darshana Patil, Timothy Crook, et al.
Indian Journal of Ophthalmology|July 30, 2024
Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study groupManisha Agarwal, Alankrita Muralidhar, Mahesh P Shanmugam, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Oncotarget|December 1, 2022
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Oncotarget|November 27, 2020
A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancerSewanti Limaye, Prashant Kumar, Ramya Pragya, et al.
Global Medical Genetics|July 24, 2024
Analyzing Cell-free Genomic DNA in Spent Culture Media: Noninvasive Insight into the BlastocystsSiddhartha Shankar Layek, Shrushti Kanani, Shilpa Doultani, et al.
Oncotarget|November 23, 2020
Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapyRajnish Nagarkar, Darshana Patil, Sewanti Limaye, et al.
Oncotarget|November 7, 2022
Addendum: Liquid biopsy and multi-analyte testing guided treatment of <i>HER2</i> positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapyRajnish Nagarkar, Darshana Patil, Sewanti Limaye, et al.
Clinical Case Reports|November 12, 2021
Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinomaSewanti Limaye, Darshana Patil, Dadasaheb Akolkar, et al.
Frontiers in Molecular Medicine|August 1, 2024
Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory CancersTimothy Crook, Darshana Patil, Rajnish Nagarkar, et al.
Cost Effectiveness and Resource Allocation : C/E|January 12, 2026
Out-of-pocket expenditure in patients with isolated traumatic brain injury: a two center cohort study, a preliminary reportHarshit Arora, Sanket Patil, Pranav Bhatia, et al.
International Journal of Cancer|December 1, 2019
Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancerDadasaheb Akolkar, Darshana Patil, Timothy Crook, et al.
Indian Journal of Ophthalmology|July 30, 2024
Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study groupManisha Agarwal, Alankrita Muralidhar, Mahesh P Shanmugam, et al.
Pageof 2